The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

American Journal of Cardiology

Volumn 84, Issue 10, 1999, Pages 1192-1197

  Shepherd, James ^a   Blauw, Gerard Jan ^b   Murphy, Michael B ^c   Cobbe, Stuart M ^a   Bollen, Edward L E M ^b   Buckley, Brendan M ^c   Ford, Ian ^a   Jukema, J Wouter ^b   Hyland, Michael ^c   Gaw, Allan ^a   Lagaay, A Margot ^b   Perry, Ivan J ^c   MacFarlane, Peter W ^a   Meinders, A Edo ^b   Sweeney, Brian J ^c   Packard, Chris J ^a   Westendorp, Rudi G J ^b   Twomey, Cillian ^c   Stott, David J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b LEIDEN UNIVERSITY   (Netherlands)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYPOCHOLESTEROLEMIC AGENT; PLACEBO; PRAVASTATIN; STEROID;

AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CEREBROVASCULAR ACCIDENT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PRAVASTATIN; PROSPECTIVE STUDIES;

EID: 0032707276     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00533-0     Document Type: Article

References (21)

1. Kannel W.B., Gordon T. Evaluation of cardiovascular risk in the elderly the Framingham Study . Bull N Y Acad Med. 54:1978;573-591.
2. Wenger N.K. Cardiovascular disease in the elderly. Curr Probl Cardiol. 10:1992;615-690.
3. Martyn C. Blood pressure and dementia. Lancet. 347:1996;1130-1131.
4. Vita A.J., Terry R.B., Hubert H.B., Fries J.F. Aging, health risks, and cumulative disability. N Eng J Med. 338:1998;1035-1041.
5. Daviglus M.L., Liu K., Greenland P., Dyer A.R., Garside D.B., Manheim L., Lowe L.P., Rodin M., Lubitz J., Stamler J. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med. 339:1998;1122-1129.
6. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state a practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res. 12:1975;189-198.
7. Sigurbjornsson S., Kjartansdottir T., Johannsson M., Kristinsson J., Sigurdsson G. A pharmacokinetic evaluation of pravastatin in middle-aged and elderly volunteers. Eur J Drug Metab Pharmacokin. 23:1998;13-18.
8. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Arch Intern Med. 153:1993;1321-1329.
9. Brand N., Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol. 112:1985;201-210.
10. Houx P.J., Jolles J., Vreiling F.W. Stroop interference aging effects assessed with the Stroop Color-Word Test . Experiment Aging Res. 19:1993;209-224.
11. Klein M., Ponds R.W.H.M., Houx P.J., Jolles J. Effect of test duration on age related differences in Stroop interference. J Clin Exptl Neuropsychol. 1:1997;66-81.
12. Smith A. The Symbol Digit Modalities Test. A neuropsychologic test for economic screening of learning and other cerebral disorders. Learning Disorders. 3:1968;82-91.
13. Lezak MD. Verbal functions and language skills. In: Lezak MD, ed. Neuropsychological Assessment. 2nd ed. New York: Oxford University Press, 1995, 554-555.
14. Collin C., Wade D.T., Davies S., Horne V. The Barthel ADL index a reliability study . Int Disabil Studies. 10:1988;61-63.
15. Fillenbaum G.G., Smyer M. The development, validity and reliability of the OARS Multidimensional Functional Assessment Questionnaire. J Gerontol. 36:1981;428-434.
16. Deelman BG, Brouwer WH, Zomeren AHv, Saan RJ. Functiestoornissen na trauma capitis. In: A Jennekens-Schinkel, JJ Diamant, HFA Diesfeldt, R Haaxma, eds. Neuropsychologie in Nederland Deventer. The Netherlands: Van Loghum Slaterus, 1980:253-281.
17. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Paris, France: Presses Universitaires de France, 1964.
18. Sacks F.M., Pfeffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., Brown L., Warnica J.W., Arnold J.M.O., Wun C.-C., Davis B.R., Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 335:1996;1001-1009.
19. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 339:1998;1349-1357.
20. Blauw G.J., Lagaay A.M., Smelt A.H.M., Westendorp R.G.J. Stroke, statins and cholesterol. A meta-analyses of randomized, placebo-controlled, double-blind trials with HMG-CoA-reductase inhibitors. Stroke. 28:1997;946-950.
21. Blauw GJ, Lagaay AM, Westendorp RGJ. Statins for the prevention of stroke. Lancet 1998;352:144.